Cetuximab for the first-line treatment of metastatic colorectal cancer. National Institute for Health and Clinical Excellence (NICE).

Guideline Title
Cetuximab for the first-line treatment of metastatic colorectal cancer.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Cetuximab for the first-line treatment of metastatic colorectal cancer. London (UK): National Institute for Health and Clinical Excellence (NICE); 2009 Aug. 37 p. (Technology appraisal guidance; no. 176).

Guideline Status
This is the current release of the guideline.

full-text:
http://guideline.gov/content.aspx?f=rss&id=15549